Research Article
Nanosuspension: An Emerging Trend for Bioavailability Enhancement of Etodolac
Figure 4
(a) Dissolution profiles of ET nanosuspensions prepared by pH shift method in phosphate buffer pH 6.8. not significant one-way ANOVA but significant two-way ANOVA. (b) Dissolution profiles of ET nanosuspensions prepared by pH shift method in phosphate buffer pH 6.8. not significant one-way ANOVA, significant two-way ANOVA.
(a) |
(b) |